T cell biology laboratory
T cells – Transcriptional & Epigenetic Regulation – Autoimmunity
The Ellmeier laboratory has a strong research interest in understanding molecular and cellular mechanisms that regulate the development, differentiation and function of T lymphocytes (T cells). The laboratory consists of an international team of scientists and is part of the Division of Immunobiology at the Institute of Immunology, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna.
T cells are key cellular players in the regulation and execution of immune responses to foreign pathogens and they also protect us against internal danger such as cancer cells. However, if dysregulated, they cause T cell-mediated diseases such as autoimmune diseases. With our studies we aim to provide important and medical relevant insight into the regulation of T cell-mediated immunity in health & disease. In ongoing studies we address the following basic and translational research questions:
• How do histone deacetylates control T cell-mediated immunity?
• What are the regulatory mechanisms that control effector T cell differentiation and function in tissues?
• How is T cell lineage identity and integrity maintained in tissues?
We are embedded in a strong collaborative research environment and the experimental strategies to address our research interests include multi-color flow-cytometry, a variety of immunological tools, biochemical and molecular approaches, retroviral-mediated gene transduction into T cells and hematopoietic stem cells, next generation sequencing and mouse molecular genetics tools combined with preclinical models for autoimmune diseases and infections.
About the Division of Immunobiology, Institute of Immunology
The Division of Immunobiology is headed by Wilfried Ellmeier and formed by the research groups of Nicole Boucheron, Wilfried Ellmeier and Shinya Sakaguchi (for information about the other groups click the names of the principal investigators). We are also committed in educating the next generation of scientists in the field of immunology by providing training opportunities for master and PhD students as well as postdoctoral fellows. Together, we form an international team of 15-20 scientists with joint lab meetings, progress reports and journal clubs as well as several joint research projects, which guarantees a stimulating research environment.
Selected recent publications
(for all publications, see here)
Nuclear receptor corepressor 1 controls regulatory T cell subset differentiation and effector function
Stolz V, de Freitas R. … and Ellmeier W. (2024). eLife, DOI: 10.7554/eLife.78738
PubMed link
FOXP3+ regulatory T cells (Treg cells) are key for immune homeostasis. Here, we uncover that nuclear receptor corepressor 1 (NCOR1) maintains naïve and effector Treg cell states via regulating their transcriptional integrity. We also reveal a critical role for this epigenetic regulator in supporting the suppressive functions of Treg cells in vivo.
CD4+ Cytotoxic T cells – Phenotype, Function and Transcriptional Networks Controlling Their Differentiation Pathways
Preglej T and Ellmeier W. (2022). Immunology Letters, DOI: 10.1016/j.imlet.2022.05.001
PubMed link
In this review, we provide a brief overview about key features of CD4 CTLs, including their role in viral infections and cancer immunity, and about the link between CD4 CTLs and immune-mediated diseases. Subsequently, we will discuss the current knowledge about transcriptional and epigenetic networks controlling CD4 CTL differentiation and highlight recent data suggesting a role for histone deacetylases in the generation of CD4 CTLs.
Histone deacetylase 1 controls CD4+ T cell trafficking in autoinflammatory diseases
Hamminger P, et al … and Ellmeier W. (2021). Journal of Autoimmunity, 119:102610. doi: 10.1016/j.jaut.2021.102610
PubMed link
CD4+ T cell trafficking is a fundamental property of adaptive immunity. In this study, we uncover a novel role for HDAC1 in controlling effector CD4+ T cell migration, thereby providing mechanistic insight into why a T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitis (EAE).
24-Norursodeoxycholic acid reshapes immunometabolism in CD8+ T cells and alleviates hepatic inflammation
Zhu C, Boucheron, N et al … and Ellmeier W, Trauner M. ,(2021). 75(5):1164-1176. doi: 10.1016/j.jhep.2021.06.036
PubMed link
24-Norursodeoxycholic acid (NorUDCA) is a novel therapeutic bile acid used to treat immune-mediated cholestatic liver diseases, such as primary sclerosing cholangitis (PSC), where dysregulated T cells including CD8+ T cells contribute to hepatobiliary immunopathology. In this study, we uncovered that NorUDCA has a direct modulatory impact on CD8+ T cells and attenuates excessive CD8+ T cell-driven hepatic immunopathology. These findings are relevant for treatment of immune-mediated liver diseases such as PSC.
The Transcription Factor MAZR/PATZ1 Regulates the Development of FOXP3+ Regulatory T Cells
Andersen L et al … and Ellmeier W. (2019). Cell Rep. 29(13):4447-4459.e6. doi: 10.1016/j.celrep.2019.11.089
PubMed link
FOXP3+ Treg cells are essential for maintaining tolerance and immune homeostasis. Here we reveal that MAZR is an important factor in regulating the delicate balance of Treg cell generation and report that MAZR expression levels play a key role in controlling Treg cell development and differentiation.
Histone deacetylase function in CD4+ T cells
Ellmeier W and Seiser C. (2018). Nature Reviews Immunology, 18, 617-634.
PubMed link
Histone deacetylases (HDACs) and histone acetyltransferases mediate reversible acetylation of histones and many other non-histone proteins to regulate gene expression and protein function. Here, we describe the myriad activities of HDACs in CD4+ T cells and the potential use of HDAC inhibitors as therapeutics for immune-mediated diseases.
